SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-022329
Filing Date
2024-06-03
Accepted
2024-06-03 10:15:24
Documents
18
Period of Report
2024-05-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50051
2 ex1-1.htm EX-1.1 78017
3 ex4-1.htm EX-4.1 116718
4 ex5-1.htm EX-5.1 16102
5 ex10-1.htm EX-10.1 273361
6 ex99-1.htm EX-99.1 12025
  Complete submission text file 0001493152-24-022329.txt   834626

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE aim-20240531.xsd EX-101.SCH 3015
8 XBRL LABEL FILE aim-20240531_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE aim-20240531_pre.xml EX-101.PRE 22360
21 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3566
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 241012328
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)